Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity

References

• GreishKEnhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicinesJ Drug Target2007157–845746417671892
   PubMed Web of Science ®Google Scholar
• MaedaHNakamuraHFangJThe EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdv Drug Deliv Rev2013651717923088862
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• AlimoradiHMatikondaSSGambleABGilesGIGreishKHypoxia responsive drug delivery systems in tumor therapyCurr Pharm Des201622192808282026898739
   PubMed Web of Science ®Google Scholar
• BaruaSMitragotriSChallenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospectsNano Today20149222324325132862
   PubMed Web of Science ®Google Scholar
• NettiPABerkDASwartzMAGrodzinskyAJJainRKRole of extracellular matrix assembly in interstitial transport in solid tumorsCancer Res20006092497250310811131
   PubMed Web of Science ®Google Scholar
• BarefordLMSwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Deliv Rev200759874875817659804
   PubMed Web of Science ®Google Scholar
• YinQShenJZhangZYuHLiYReversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumorAdv Drug Deliv Rev20136513–141699171523611952
   PubMed Web of Science ®Google Scholar
• SelbyLICortez-JugoCMSuchGKJohnstonAPRNanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticlesWiley Interdiscip Rev Nanomed Nanobiotechnol201795e1452
   Web of Science ®Google Scholar
• KumarVHongSYMaciagAEStabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and double JS-K, through incorporation into PEG-protected nanoparticlesMol Pharm20107129129820000791
   PubMedGoogle Scholar
• MillerMRMegsonILRecent developments in nitric oxide donor drugsBr J Pharmacol2007151330532117401442
   PubMed Web of Science ®Google Scholar
• GilesNMKumariSGangBPYuenCWBillaudEMGilesGIThe molecular design of S-nitrosothiols as photodynamic agents for controlled nitric oxide releaseChem Biol Drug Des201280347147822642531
   PubMed Web of Science ®Google Scholar
• KumariSSammutIAGilesGIThe design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAPEur J Pharmacol201473716817624858367
   PubMed Web of Science ®Google Scholar
• LowensteinCJNitric oxide regulation of protein trafficking in the cardiovascular systemCardiovasc Res200775224024617490627
   PubMed Web of Science ®Google Scholar
• GreishKSawaTFangJAkaikeTMaedaHSMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumoursJ Control Release200497221923015196749
   PubMed Web of Science ®Google Scholar
• KaurPNagarajaGMZhengHA mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseBMC Cancer20121212022452810
   PubMed Web of Science ®Google Scholar
• VermesIHaanenCSteffens-NakkenHReutelingspergerCA novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin VJ Immunol Methods1995184139517622868
   PubMed Web of Science ®Google Scholar
• Rello-VaronaSHerrero-MartínDLópez-AlemanyRMuñoz-PinedoCTiradoOM“(Not) all (dead) things share the same breath”: identification of cell death mechanisms in anticancer therapyCancer Res201575691391725724677
   PubMed Web of Science ®Google Scholar
• LoewLMCarringtonWTuftRAFayFSPhysiological cytosolic Ca2+ transients evoke concurrent mitochondrial depolarizationsProc Natl Acad Sci U S A1994912612579125837809081
   PubMed Web of Science ®Google Scholar
• FarkasDLWeiMDFebbrorielloPCarsonJHLoewLMSimultaneous imaging of cell and mitochondrial membrane potentialsBiophys J1989566105310692611324
   PubMed Web of Science ®Google Scholar
• ChouTCDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
   PubMed Web of Science ®Google Scholar
• GreenPSLeeuwenburghCMitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosisBiochim Biophys Acta2002158819410112379319
   PubMed Web of Science ®Google Scholar
• DoutheilJAlthausenSTreimanMPaschenWEffect of nitric oxide on endoplasmic reticulum calcium homeostasis, protein synthesis and energy metabolismCell Calcium200027210711510756977
   PubMed Web of Science ®Google Scholar
• BossOSamecSKühneFUncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperatureJ Biol Chem19982731589417036
   PubMed Web of Science ®Google Scholar
• ZhangSLiJLykotrafitisGBaoGSureshSSize-dependent endocytosis of nanoparticlesAdv Mater20092141942419606281
   PubMed Web of Science ®Google Scholar
• Pierzyńska-MachAJanowskiPADobruckiJWEvaluation of acridine orange, LysoTracker Red, and quinacrine as fluorescent probes for long-term tracking of acidic vesiclesCytometry A201485872973724953340
   PubMedGoogle Scholar
• TraganosFDarzynkiewiczZLysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulationsMethods Cell Biol1994411851947532261
   PubMed Web of Science ®Google Scholar
• BarenholzYDoxil® – the first FDA-approved nano-drug: lessons learnedJ Control Release2012160211713422484195
   PubMed Web of Science ®Google Scholar
• BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
   PubMed Web of Science ®Google Scholar
• RigantiCMiragliaEViarisioDNitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug effluxCancer Res200565251652515695394
   PubMed Web of Science ®Google Scholar
• TanLHuangRLiXLiuSShenYMControllable release of nitric oxide and doxorubicin from engineered nanospheres for synergistic tumor therapyActa Biomater20175749851028499633
   PubMed Web of Science ®Google Scholar
• SongQTanSZhuangXNitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicinMol Pharm201411114118412925222114
   PubMedGoogle Scholar
• KashfiKRigasBMolecular targets of nitric-oxide-donating aspirin in cancerBiochem Soc Trans200533Pt 470170416042578
   PubMedGoogle Scholar
• RiegerAMNelsonKLKonowalchukJDBarredaDRModified annexin V/propidium iodide apoptosis assay for accurate assessment of cell deathJ Vis Exp2011502597
   Google Scholar
• WinkDAMitchellJBChemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxideFree Radic Biol Med1998254–54344569741580
   PubMed Web of Science ®Google Scholar
• SenSKawaharaBChaudhuriGMitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancerFree Radic Biol Med20135721022023089229
   PubMed Web of Science ®Google Scholar
• MimnaughEGTrushMABhatnagarMGramTEEnhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycinBiochem Pharmacol19853468478563977958
   PubMed Web of Science ®Google Scholar
• GoormaghtighEPollakisGRuysschaertJMMitochondrial membrane modifications induced by adriamycin-mediated electron transportBiochem Pharmacol19833258898936838634
   PubMed Web of Science ®Google Scholar
• BrownGCNitric oxide and mitochondrial respirationBiochim Biophys Acta199914112–335136910320668
   PubMed Web of Science ®Google Scholar
• RigantiCMiragliaEViarisioDNitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug effluxCancer Res200565251652515695394
   PubMed Web of Science ®Google Scholar
• FergusonSMDe CamilliPDynamin, a membrane-remodelling GTPaseNat Rev Mol Cell Biol2012132758822233676
   PubMed Web of Science ®Google Scholar
• WangGMoniriNHOzawaKStamlerJSDaakaYNitric oxide regulates endocytosis by S-nitrosylation of dynaminProc Natl Acad Sci U S A200610351295130016432212
   PubMed Web of Science ®Google Scholar
• EvansCJPhillipsRMJonesPFA mathematical model of doxorubicin penetration through multicellular layersJ Theor Biol2009257459860819183560
   PubMed Web of Science ®Google Scholar
• KimJYungBCKimWJChenXCombination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapyJ Control Release201726322323028034787
   PubMed Web of Science ®Google Scholar
• PetersenNHOlsenODGroth-PedersenLTransformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinaseCancer Cell201324337939324029234
   PubMed Web of Science ®Google Scholar
• KirkegaardTRothAGPetersenNHHsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathologyNature2010463728054955320111001
   PubMed Web of Science ®Google Scholar
• SarkarSKorolchukVIRennaMComplex inhibitory effects of nitric oxide on autophagyMol Cell2011431193221726807
   PubMed Web of Science ®Google Scholar
• YuHXiaoYJinLA lysosome-targetable and two-photon fluorescent probe for monitoring endogenous and exogenous nitric oxide in living cellsJ Am Chem Soc201213442174861748923043509
   PubMed Web of Science ®Google Scholar
• RepnikUStokaVTurkVTurkBLysosomes and lysosomal cathepsins in cell deathBiochim Biophys Acta201218241223321914490
   PubMed Web of Science ®Google Scholar
• KroemerGJäätteläMLysosomes and autophagy in cell death controlNat Rev Cancer200551188689716239905
   PubMed Web of Science ®Google Scholar
• LiYSunYJingLLysosome inhibitors enhance the chemotherapeutic activity of doxorubicin in HepG2 cellsChemotherapy2017622859327764836
   PubMed Web of Science ®Google Scholar
• KinoshitaRIshimaYChuangVTGImproved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimerBiomaterials201714016216928651144
   PubMed Web of Science ®Google Scholar
• MaedaHMacromolecular therapeutics in cancer treatment: the EPR effect and beyondJ Control Release2012164213814422595146
   PubMed Web of Science ®Google Scholar
• IshimaYInoueAFangJPoly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxideCancer Sci2015106219420025457681
   PubMed Web of Science ®Google Scholar
• IshimaYAlbumin-based nitric oxide traffic system for the treatment of intractable cancersBiol Pharm Bull201740212813428154250
   PubMed Web of Science ®Google Scholar
• GreishKFateelMAbdelghanySRachelNAlimoradiHBakhietMSildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancerJ Drug Target201826761061529148852
   PubMed Web of Science ®Google Scholar
• ChoudhariSKChaudharyMBagdeSGadbailARJoshiVNitric oxide and cancer: a reviewWorld J Surg Oncol20131111823718886
   PubMed Web of Science ®Google Scholar
• MorikawaSBalukPKaidohTHaskellAJainRKMcDonaldDMAbnormalities in pericytes on blood vessels and endothelial sprouts in tumorsAm J Pathol20021603985100011891196
   PubMed Web of Science ®Google Scholar
• BonavidaBGarbanHNitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeuticsRedox Biol2015648649426432660
   PubMed Web of Science ®Google Scholar
• GreishKTaurinSMorsyMAThe effect of adjuvant therapy with TNF-α on animal model of triple-negative breast cancerTher Deliv20189533334229681232
   PubMed Web of Science ®Google Scholar